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Abstract Happiness and well-being are in part heritable, but modifiable traits. The
promotion of well-being and happiness, much like the primary prevention of non-
communicable diseases (NCD), will become increasingly important in a world that
is facing an NCD epidemic due to demographic aging and urbanization. The costs
for the often lifelong treatment of NCDs are already high and may increase further
with the arrival of expensive personalized medicine. The effective promotion of
happiness at the individual and population level in order to guide policy requires a
causal and mechanistic understanding of its modifiable determinants. With more
than half of the world’s population living in cities, it becomes, for example,
important to understand how environmental, social, and lifestyle characteristics of
urban life influence well-being. Yet, the correlation between many of these factors
and the fact that they act in concert poses a large challenge in causal inference. The
-omics biomarkers which form a pillar of personalized medicine are at the same
time essential research instruments of modern-day observational epidemiology. The
paper discusses how they can be applied to overcome the challenges researchers
face in studies on the association of complex risk and protective patterns with
specific well-being phenotypes and their relation to diseases. Important concepts are
discussed in the context of well-being that were recently developed by epidemiol-
ogists to stimulate more investments into the understanding of the modifiable part of
health (e.g., Exposome; Meet-in-the-Middle; Mendelian Randomization) to match
the huge investments that went into genetic research.
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1 Happiness and well-being are modifiable
The World Happiness Report 2016 Update (http://worldhappiness.report/) ranks 156
countries by their level of happiness. The fact that most countries routinely include in
their national surveys at least a basic indicator of happiness reflects the value that these
days countries and governments give to the promotion of happiness for their people.
Happiness is a proxy of ‘‘human development’’ at the societal level. Happiness is
modifiable—we are not doomed by our genes to be unhappy. Four important aspects
provide supportive evidence for the long-term modifiability of happiness: First, the
inequality in the level of happiness observed between andwithin countries; second, the
time trends in country-specific happiness; third, the nation-specific shapes of the
curves plotting Cantril’s Ladder Score of happiness on age (Steptoe et al. 2015); and
fourth, migrants’ happiness level is closer to the happiness level of residents in the
destination rather than in the home country (Frank et al. 2015). According to the most
recent World Happiness Report, inequalities in happiness are increasing within
countries and are themselves an important determinant of a countries happiness level.
According to the report, about 75% of the difference in happiness between countries
and regions is explained by the following six key factors: GDP per capita; healthy
years of life expectancy; social support; trust; perceived freedom to make life deci-
sions; and generosity. Yet, this reflects an ecological association rather than an
association of parameters collected at the individual level. Furthermore, determinants
of happiness are likely to differ by the happiness phenotype studied. The construct
validity of ‘‘happiness’’ is difficult to demonstrate. There are reasons and interests in
exploring the determinants of the different facets of happiness andwell-being. Steptoe
et al. (2015), for example, listed the following three dimensions of well-being: life
satisfaction (evaluative); recent happiness or sadness (hedonic); and purpose (eudai-
monic), but other definitions exist.
2 The challenges in identifying the modifiable determinants
of happiness
In order to promote happiness in an efficient manner, it is essential to understand the
modifiable factors influencing phenotypes of well-being at the individual level. The
challenges ahead are comparable to the ones faced by chronic disease prevention.
Happiness, likemental health or age-related diseases, is the result of the multifactorial
influence of risk and protective factors related to aspects including genetics,
personality, personal and family history, lifestyle and health as well as political,
structural, social and environmental circumstances of living. The fraction of happiness
attributable to specific risk and protective patterns depends on the specific well-being
dimension used. The following are some of the challenges in identifying modifiable
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determinants of happiness phenotypes: First, the effects of each determinant alone are
small and require large studies to be detected with sufficient statistical power. Second,
only longitudinal studies allow disentangling cause and effect of correlated states of
well-being such as aging, happiness, health, and life conditions. Prospective studies
with repeated interrogation of their participants allow for a more clear time-sequence
of events to mitigate the problem of reverse causation. Third, the potentially long
latency of effects accentuates the risk of exposure misclassification, particularly if
exposure is assessed retrospectively. Consistent with the existence of very long
latencies or long-lasting effects is, for example, the association between childhood
trauma and inflammatory gene expression in the blood later in adulthood (Levine et al.
2015). Fourth, the identification of causal risk and protective factors of relevance to the
promotion of happiness is hindered by confounding which may be accentuated by the
complexity of the happiness construct. For example,withmore than half of theworld’s
population living in an urban environment, it is relevant to understand the influence of
components of life in the city on happiness and well-being (Lambert et al. 2015). Yet,
urban life goes along with traffic noise and air pollution, altered social networks,
artificial light pollution, lack of and access to different types of greenspace, and altered
lifestyle. These factors can all be highly correlated, albeit in a spatial-specific context,
which complicates the identification of confounders (Foraster 2013).
3 Clinical versus public health and epidemiologic research utility of
-omics biomarkers
Personalized medicine is a very promising approach to improve health outcomes at an
individual level. However, the existing unmet needs and health inequalities may widen
further with personalizedmedicine because of its high costs,with obvious repercussions
at an individual and population level on perceived happiness (Abettan 2016).
Personalized health builds on the unprecedented advances in high-through-put
processing of big data as it becomes available from technological advances in
eHealth, imaging, and molecular-omics analysis. The genetic and genomic
characterization of diseases has proven clinical utility in refining disease classifi-
cation, such as observed in the field of oncology where, for example, non-small cell
lung cancer has evolved from a single disease phenotype to a collection of
molecular sub-phenotypes with different novel treatment options. In contrast, the
clinical utility of premorbid risk prediction toward the materialization of the
promised shift from reactive to more preventive medicine is lagging behind
expectations when diseases with complex etiology are concerned. Over the past
decade, the intense effort to elucidate the genetic architecture of complex diseases
etiologies in the context of hundreds of genome-wide association studies (GWAS)
has uncovered thousands of gene variants associated firmly with these diseases,
albeit only explaining in most cases a small proportion of disease risk (Rappaport
2016). While there is clear clinical utility of genetic testing for monogenetic
disorders (e.g., utility for family planning, neonatal screening, timely and targeted
preventive and therapeutic intervention), the clinical utility of genetic risk
prediction for complex diseases remains uncertain in most cases. The expected
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individual value of genetic risk prediction in chronic, age-related diseases lies in a
stimulus for altered behavior in persons at risk for a chronic disease. Yet, according
to a recent meta-analysis, evidence for alterations in screening attendance or
lifestyle (e.g., smoking, nutrition, alcohol consumption) stimulated by a genetic test
is clearly lacking (Hollands et al. 2016). Would it make sense to predict the
likelihood of being unhappy in specific situations through a genetic test? While
currently gene tests for predicting unhappiness and its sub-phenotypes that are
sufficiently predictive at the individual level do not exist, such a test could in fact be
of value in certain clinical situations to capture vulnerability to long-lasting distress
following a diagnosis; to predict which patients will suffer from mood disturbances
when taking a specific chemotherapeutic regimen; to predict pharmacological
response to the treatment of disturbed well-being; and therefore in the end to
identify patients benefitting from interventions to sustainably increase happiness
and well-being (Sprangers et al. 2010). Even if such tests were identified in the
future, it will be important to test and demonstrate their clinical validity and utility.
What is often overlooked in discussions about the current limitations in the
clinical utility of -omics biomarkers is their utility for public health and
epidemiologic research that aims to uncover the modifiable exogenous determinants
of health and disease. Biomarkers offer unprecedented opportunities for overcoming
some of the research challenges in this endeavor as listed above. As biomarkers of
extrinsic exposure, they allow capturing exposures inside the body in the sense of
biomonitoring and reflect the dose that actually entered the body to exert its
biological action. Depending on the biomarker’s half-life, they may also capture
exposure history such as in the case of smoking, which leaves epigenetic marks in
the blood that are still visible more than 20 years after smoking cessation (Shenker
et al. 2013). These characteristics of biomarkers have the potential to decrease the
problem of exposure misclassification. As biomarkers of phenotype or disease, they
offer the possibility to improve the classification of neighboring happiness
dimensions, of understanding of molecular profiles underlying sub-phenotypes
and of how these molecular profiles are altered by exogenous modifiable exposures.
Finally, as biomarkers of susceptibility such as in the case of genetic risk markers
they help identify subjects more likely to develop a disease phenotype in response to
an adverse risk pattern.
The value of biomarkers has gained tremendous momentum with the advent of
-omics technologies that allow investigating disease etiologies and risk factor
mechanism agnostically without the limitations of current biological understanding.
The first agnostic approaches to disease understanding were GWAS, in which
thousands of genetic variants are tested for disease association. The penalty of very
stringent p values to account for spurious results due tomultiple testing was overcome
in part by the formation of large research consortia that combined phenotype and
genome-wide data in the context of large meta-analysis to increase statistical power
and detect true effects when they existed. The biggest value of GWAS was the novel
insight they provided in part into themolecular pathways underlying specific diseases.
But given that genetic variation alone explains a very small percentage of most
common complex diseases, the exposome concept was put forward first by C. Wild
(2005) to point to the importance of matching efforts invested into genetic research
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with efforts invested into a novel exposure understanding. The exposome has been
defined as the totality of external and internal exposures impacting on health and
diseases over the life course. The personalized health technologies which extend from
-omics biomarkers to the personalized sensoring of lifestyle, social contacts, and
environmental contexts and also include the availability of high-resolution geographic
information system (GIS) data now facilitate capturing the internal and external
geographic information system of humans (Topol 2014) and thus an individual’s
exposome. We now have at hands the tools to characterize a person’s molecular
profile, environment, behavior, and well-being at any specific point in time which
allows for new and hypothesis-free approaches as a further step toward causal
inference and mechanistic understanding of modifiable health risks in the context of
exposome-wide association studies that profile exposures also in the form of
biomarkers (Rappaport 2016).
From a public health perspective, research into the urban exposome and its
relation to health and well-being is of high priority. By now, more than half of the
world’s population is living in an urban environment. Urbanization is a major driver
of the epidemiological transition from the predominance of communicable to non-
communicable diseases. The changes in the health profile combined with changes in
the environmental, occupational, and social context accompanying life in the city
also impact on well-being and happiness (Mehrdadi et al. 2016). On the one hand,
the health relevance of the urban exposome can be studied one risk factor and one
health outcome at a time, using -omics biomarkers to improve causal and
mechanistic understanding of these relationships. On the other hand, the -omics
biomarkers could be applied to the search for molecular pathways that interlink
several exposures and several diseases. Such pathways, if they exist and are
modifiable, are of considerable public health relevance, because they would account
for a substantial disease and risk factor burden (Fig. 1). The following evidence
supports the existence of public health relevant pathways—pathways that mediate
the association of several risk factors with several diseases: First, the incidence of
several chronic diseases increases in parallel with aging. Second, a group of
centenarians exists that is often free of any chronic disease until very old age,
whereas persons dying at a younger age are often faced with co-morbidities
(Ailshire et al. 2015). Third, biological pathways exist that have been linked to a
diversity of risk factors prevalent in urban environments and at the same time to
numerous age-related diseases. That is true for oxidative stress and systemic low-
grade inflammation, two interrelated mechanisms. Oxidative stress and low-grade
systemic inflammation are increased by several factors such as smoking, air
pollution, and obesity, and they are elevated in patients with different diseases such
as COPD, diabetes, or cardiovascular disease (Probst-Hensch 2010). A pro-
inflammatory state called inflammaging is present in older persons (Franceschi and
Campisi 2014). Oxidative stress and inflammation may contribute to the parallel
increase of chronic disease with aging through the peroxidation of nucleic acids,
bases, lipids, proteins, and carbohydrates. It may then ultimately be the accumu-
lation of damage to biomolecules in various cells and organs which explains the
parallel increase in the incidence of several age-related diseases in response to
inflammatory and oxidative risk factors. If that was true, if in fact oxidative stress
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was at least in part a causal mediator between the urban exposome (several
exposures common to life in the city) and phenome (several diseases common in
populations living in the city and achieving older ages), then the modification of
oxidative stress through primary prevention would be of high priority. An example
for a cost-effective intervention to decrease oxidative stress could be the
recommendation for a higher intake of antioxidant food items.
The impact of life in the city or components thereof and the mediating role of
oxidative stress and systemic low-grade inflammation on happiness and well-being
phenotypes and their downstream health outcomes have not been studied in the
context of an exposome approach. Yet, it is well established that emotional
experiences influence and are influenced by circulating pro-inflammatory cytokines.
Pro-inflammatory stressors and emotions both activate the hypothalamic–pituitary–
adrenal (HPA) axis and/or the sympathetic nervous system (SNS) (Tuck et al.
2016). Of interest in the context of the urban exposome is the fact that traffic noise,
for example, is thought to impact on the same systems and thereby exerts its health
effects (Recio et al. 2016).
The following two paragraphs outline the research value of biomarkers in the
context of studying the influence of components of urban life on happiness
phenotypes and their health consequences, with a particular focus on the role of
traffic noise, light pollution, and obesity on well-being and its potential downstream
health cardiometabolic consequences (Fig. 2).
3.1 Biomarkers toward understanding the happiness exposome
Biomarkers can be used at several steps when investigating the happiness
exposome.
Fig. 1 Urban exposome and phenome—interlinked by public health relevant pathways?
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3.1.1 A first research question is on the causal role of inflammation on well-being
and happiness
On the one hand, obesity (Festa et al. 2001), traffic-related air pollution and noise
(Mu¨nzel et al. 2016), psychosocial stress (Das 2016), as well as light exposure and
associated sleep disturbance (McAlpine and Swirski 2016) have all been associated
with low-grade systemic inflammation. On the other hand, pro-inflammatory profiles
have been associated with phenotypes of well-being (Janicki-Deverts et al. 2007;
Steptoe et al. 2008; Tuck et al. 2016). But because low-grade systemic inflammation is
related to numerous other exposures and phenotypes, the assessment of its causal role
in well-being is hampered by potential confounding. An approach to improve causal
understanding is the use of genetic variants as instrumental variables in the context of
the Mendelian randomization principle. To capture chronic inflammation well, the
biomarker C-reactive protein (CRP) has a couple of attributes (Pepys and Hirschfield
2003). Circulating CRP has been associated with various quality-of-life indicators
(Nowakowski 2014; Hamer and Chida 2011). Circulating CRP is in part genetically
determined. Unlike circulating CRP, genetic determinants of CRP are randomized to
gametes at the time point of their formation and they are therefore not likely subject to
confounding. Any association between CRP gene variants and happiness-related
phenotypes would provide evidence for a causal effect in the above-cited associations
of systemic inflammation with well-being. In fact, a recent Mendelian randomization
approach supports a causal role of low-grade systemic inflammation in dispositional
optimism in overweight and obese persons (Rius-Ottenheim et al. 2012).
3.1.2 A second research question is whether light pollution in the city impacts
on well-being and whether any observed association is mediated
by alterations in the circadian rhythm
Circadian rhythms are generated by endogenous biological clocks that are regularly
set or modulated by environmental cues such as the daily light–dark cycle. Artificial
Fig. 2 Molecular fingerprints in the pathway from life in the city to happiness and health
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light-pollution affects circadian rhythmicity by impacting on melatonin secretion.
Melatonin in addition to its sleep regulatory effect also exhibits anti-oxidative
properties (Gabriel et al. 2017). Findings from the Gross National Happiness study
in Buthan point to the role of sleep in self-reported health status, an important
indicator of a high happiness score (Sithey et al. 2017). Both disturbances in
circadian rhythm and in sleep have been associated with mortality and cardiovas-
cular morbidity, and with mental health disorders and with psychological well-being
(Espie et al. 2016; Harb et al. 2015). The endogenous clock for circadian rhythm is
determined at its core by transcriptional–translational feedback loops consisting of
two transcription factors (CLOCK/NPAS2; BMAL1/BMAL2) that activate the
transcription of target genes such as PERIOD (PER)1, PER2, PER3, and
CRYPTOCHROME (CRY)1 and CRY2 (Yurtsever et al. 2016). Genetic variation
in PER3 was shown to impact on melatonin suppression in response to light. A
cross-over design study examined eighteen healthy young men with different
genotypes in PER3, and the authors could demonstrate that sleep responses to non-
image-forming light depended on the PER3 genotype (Chellappa et al. 2014). It
would be of interest to follow up on this finding by asking the question whether an
association between light pollution and well-being-related phenotypes was also
modified by genetic variants in PER3. If so, the gene-environment interaction would
lend support to the hypothesis of a mediating role of altered circadian rhythm in the
pathway from light pollution to well-being.
3.1.3 A third research question is about the mechanisms which may mediate
an association between traffic noise and well-being
Today’s option for hypothesis-free approaches to studying exposure mechanisms is
of particular interest for noise exposure, which exerts broad health effects, yet
remains very poorly understood at the molecular level. Exposure to noise from
traffic is thought to exert its health effects through conscious pathways (e.g., noise
annoyance) as well as sub-conscious pathways (e.g., heart rate variability), both of
which may influence the HPA axis and lead to allostatic load (‘‘the cost of chronic
exposure to fluctuating or heightened neural or neuroendocrine response resulting
from the repeated or chronic environmental challenge that an individual reacts to as
being particularly stressful’’—McEwen and Stellar 1993) (Recio et al. 2016).
Annoyance from noise impacts on worries and emotions and thus well-being (van
den Berg et al. 2015). The health effects of traffic noise in part overlap with the
health effects of air pollution raising concerns about potential confounding and
causality of noise effects (Foraster 2013). Circulating -omics biomarkers that are
associated with both, the external exposure of interest and the phenotype of interest
(after adjustment for the external exposure of interest) can inform about molecular
pathways mediating exposure effects on health (Chadeau-Hyam et al. 2011). This
meet-in-the-middle approach to improve mechanistic and causal understanding of
exposure disease relationships is currently applied toward understanding of the air
and water pollution exposome (Vineis et al. 2016). Of interest, when 280 blood
metabolites were investigated for mediating the effect of air pollution on lung
function, the meet-in-the-middle approach pointed to alpha-tocopherol, the main
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form of anti-oxidative Vitamin E in the circulation (Menni et al. 2015). The
untargeted meet-in-the-middle approach using -omic biomarkers has not been
applied to noise effects and to investigate how the noise and air pollution exposome
differ.
3.2 Biomarkers toward understanding the happiness-related phenome
Biomarkers can be used at several steps of studying the molecular patterns
underlying different happiness phenotypes and mediating their health consequences.
3.2.1 A first research question is about molecular profiling of different happiness-
related phenotypes
This parallels the molecular profiling of chronic disease phenotypes such as, for
example, asthma (Wenzel 2016). The refined classification of phenotypes is
important for identifying modifiable determinants of happiness and well-being and
to improve the construct validity of these phenotypes. Combining phenotypes with
different etiological origins into a single outcome may mask risk factor effects in
subgroups and bias the associations. The comparison of -omics marker profiles in
accessible biospecimens such as blood between different well-being phenotypes can
inform about molecular differences. The molecular profiles of well-being pheno-
types can also be studied in a dynamic approach over a period of months, because
phenotypes like well-being are likely also to be characterized by short- and
medium-term molecular fluctuations of molecular networks. This concept has
recently been applied to a single participant who was characterized in-depth over
the period of 532 days for dynamics of brain function and their relation to
psychological and biological parameters (Poldrack et al. 2015). Molecular profiles
related to well-being can also serve as endpoints in intervention studies for
promoting happiness, as recently shown for a Yoga intervention that was able to
reduce inflammation-related biomarkers among fatigued breast cancer survivor
(Irwin et al. 2014) and family dementia care givers (Black et al. 2013). Finally,
genetic determinants of happiness-related phenotypes can provide new insights into
the molecular basis of happiness. Twin studies point to an important influence of
genetic background for well-being. According to recent meta-analysis of heritability
estimates for well-being, based on data from over 55,000 individuals, the average
heritability of satisfaction with life was 32% (95% confidence intervals (29–35)—
Bartels 2015). Much like in candidate gene studies for chronic diseases, the
interrogation of genetic variation in genes related to biological pathways of
hypothesized relevance to quality of life produced inconsistent evidence (Sprangers
et al. 2014). Genome-wide data produced in the context of sufficiently powered
study consortia and allowing for a hypothesis-free search is more promising. Data
from the UK Biobank were used for assessing whether polygenetic risk scores found
in genome-wide association studies on personality traits such as extraversion and
neuroticism were associated with phenotypes of well-being. The authors reported
positive associations between extraversion-related gene scores and well-being
measures, and inverse associations between neuroticism-relate gene scores and life
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satisfaction (Weiss et al. 2016). Results from the first genome-wide association
study on overall well-being and happiness were published only recently by the
Social Science Genetic Association Consortium (www.ssgac.org). Data from nearly
300,000 persons were studied for genetic association with subjective well-being,
depressive symptoms, and neuroticism (Okbay et al. 2016). Variants in three dif-
ferent genes were associated with subjective well-being and how happy a person
reports to be in life. In addition 2 and 11 gene variants were associated with
depressive symptoms and neuroticism, respectively. Of interest, the authors found
enrichment of central nervous system-related gene variants for all three phenotypes
and of adrenal/pancreas for subjective well-being and depressive symptoms. The
adrenal glands produce several hormones, including cortisol, epinephrine, and
norepinephrine, involved in the bodily regulation of mood and stress. While the
reported associations were strong at the statistical significance level, the size of the
associations was small compared to modifiable determinants of happiness
constructs.
3.2.2 A second research question is whether happiness and well-being are
independent risk factors for poor health and mortality
Being unhappy is related to poor health. This can be the result of a direct effect of
being unhappy on morbidity and mortality or due to the effect of being unhappy on
poor lifestyle. According to data from the large, prospective UK Million Women
study being happy or being unhappy was not associated with overall mortality
beyond its influence on behavioral risk factors and beyond its association with poor
health at baseline (Liu et al. 2016). To investigate the influence of well-being
phenotypes on disease-specific morbidity rather than mortality, Mendelian
randomization approaches could be envisaged based on genetic variants identified
in the recent GWAS on well-being-related sub-phenotypes (Okbay et al. 2016). The
association of well-being-related gene variants as instrumental variable rather than
of the well-being phenotype itself with the chronic disease risk of interest would be
interrogated.
3.2.3 A third research question is about the molecular mechanisms mediating
the effect of well-being on chronic disease outcomes
In following up on the meet-in-the-middle approach described above toward
understanding the happiness exposome, an equivalent approach can also be applied
toward understanding the happiness-related phenome, with well-being phenotypes
now being the ‘‘exposure’’ and the chronic disease of interest the outcome. Of
interest in that respect would be the agnostic study of the well-being-related
methylome. The first epigenome-wide association study (EWAS) on well-being was
recently published in subjects of the longitudinal survey studies of the Netherlands
Twin Register (NTR). The interrogation of more than 400,000 DNA methylation
signals for association with well-being pointed to an enrichment of methylation
signals related to several central nervous system categories (Baselmans et al. 2015).
If the well-being-associated methylation signals were also related to chronic disease
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outcomes, this could inform about biological mechanisms mediating health effects
of well-being. Epigenetic studies on DNA methylation are also promising for
studying transgenerational aspects of well-being. Stress- and well-being-related
methylation signals may be passed on from one generation to the next. The
methylation of FKBP5, an important regulator of the glucocorticoid receptor, was
recently found to be altered both in holocaust survivors and their adult offspring,
pointing to a transgenerational effect of preconception parental trauma (Yehuda
et al. 2016).
4 Conclusions
Being one of the pillars of personalized health and medicine, -omics biomarkers
have become important instruments for epidemiological studies into the possible
causes and consequences of health, well-being, and diseases. They allow
overcoming some of the limitations of observational research and form magnifying
glasses for looking into the potential molecular basis of health and happiness
determinants. Research into the primary prevention of chronic diseases and into the
maintenance of happiness and well-being becomes increasingly important in the
light of a global population that is increasing in number, undergoes demographic
aging, and is facing an associated global non-communicable disease (NCD)
epidemic. The costs for the treatment of NCDs will be overwhelming the healthcare
systems in low- and middle-income countries, and the advent of increasingly
expensive personalized treatments for these NCDs is already starting to challenge
healthcare systems in high-income countries. It is therefore important that happiness
and well-being research is becoming recognized as an important aspect of
personalized health.
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